Exploring Disease Modifying Therapies In Multiple Sclerosis
Let's dive into the details surrounding Disease Modifying Therapies In Multiple Sclerosis.
- An elucidation of the American Academy of Neurology guidelines with regard to
- What is the best
- Patients with
- The panel takes time to define the cost of
- What is the best
In-Depth Information on Disease Modifying Therapies In Multiple Sclerosis
For most people, it's better to start taking drugs for In this video we chat to neurologist Dr Sharmilee Gnanapavan about Barbara S. Giesser, MD, FAAN, FANA, is an internationally recognized clinician and award-winning educator who has specialized ... Alex Rae-Grant, MD, FAAN, FRCPC, lead author of the guideline, and Ruth Ann Marrie, MD, PhD, FRCPC, co-author of the ...
Listen as Dr. Alissa Willis, neurologist at Cleveland Clinic Mellen Center for
That wraps up our extensive overview of Disease Modifying Therapies In Multiple Sclerosis.
